Zobrazeno 1 - 10
of 733
pro vyhledávání: '"Krabbe LM"'
Autor:
Frazer R; Velindre Cancer Centre, Cardiff, CF14 2TL, UK. ricky.frazer@wales.nhs.uk., Arranz JÁ; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Estévez SV; Hospital Universitario Lucus Augusti (HULA), Lugo, Spain., Parikh O; Lancashire Teaching Hospitals NHS Foundation Trust, Chorley, UK., Krabbe LM; Klinik für Urologie, Vivantes Humboldt-Klinikum, Berlin, Germany., Vasudev NS; Leeds Institute of Medical Research at St James's, Leeds, UK., Doehn C; Urologikum Lübeck, Lübeck, Germany., Marschner N; Clinical Research Institute IOMEDICO, Freiburg, Germany., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Ince W; Department of Oncology, Cambridge University NHS Foundation Trust, Cambridge, UK., Goebell PJ; Uniklinik Erlangen, Urologische und Kinderurologische Klinik, Erlangen, Germany.
Publikováno v:
Current oncology reports [Curr Oncol Rep] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.
Autor:
Silberg M; Department of Urology, Marien Hospital Herne, University Hospital of the Ruhr University of Bochum, Herne, Germany. Electronic address: matteo.silberg@elisabethgruppe.de., Krabbe LM; Department of Urology, Vivantes Network for Health, Berlin, Germany., Bögemann M; Department of Urology, University Hospital Muenster, Muenster, Germany., Schrader AJ; Department of Urology, University Hospital Muenster, Muenster, Germany., Tully K; Department of Urology, Marien Hospital Herne, University Hospital of the Ruhr University of Bochum, Herne, Germany., Schlack K; Department of Urology, University Hospital Muenster, Muenster, Germany.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102164. Date of Electronic Publication: 2024 Jul 17.
Autor:
Michel MS; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland. Maurice-Stephan.Michel@medma.uni-heidelberg.de.; Klinik für Urologie und Urochirurgie, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland. Maurice-Stephan.Michel@medma.uni-heidelberg.de., Gschwend JE; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Wullich B; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Krege S; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Bolenz C; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Merseburger AS; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Krabbe LM; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Schultz-Lampel D; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., König F; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Haferkamp A; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland., Hadaschik B; Deutsche Gesellschaft für Urologie, Geschäftsstelle Berlin, Martin-Buber-Straße 10, 14163, Berlin, Deutschland.
Publikováno v:
Urologie (Heidelberg, Germany) [Urologie] 2024 Sep; Vol. 63 (9), pp. 893-898. Date of Electronic Publication: 2024 Aug 12.
Autor:
Efstathiou E; Houston Methodist, Houston, Texas, USA. Electronic address: eefstathiou@houstonmethodist.org., Merseburger A; University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Liew A; Oxford PharmaGenesis Group Pty Ltd, Melbourne, Australia., Kurtyka K; Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA., Panda O; Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA., Dalechek D; Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA., Heerdegen ACS; Janssen Global Commercial Strategy Organization, Raritan, New Jersey, USA., Jain R; Janssen Global Commercial Strategy Organization, Raritan, New Jersey, USA., De Solda F; Janssen Global Commercial Strategy Organization, Raritan, New Jersey, USA., McCarthy SA; Janssen Research & Development, Raritan, New Jersey, USA., Brookman-May SD; Janssen Research & Development, Spring House, Pennsylvania, USA; Ludwig-Maximilians-University, Munich, Germany., Mundle SD; Janssen Research & Development, Raritan, New Jersey, USA., Yu Ko W; University of British Columbia Men's Health Research Program, Vancouver, British Columbia, Canada., Krabbe LM; Vivantes Hospital Network for Health, Berlin, Germany.
Publikováno v:
ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 103007. Date of Electronic Publication: 2024 May 14.
Autor:
Eminaga O; AI Vobis, Palo Alto, CA 95054, USA., Leyh-Bannurah SR; Department of Urology, Pediatric Urology and Uro-Oncology, Prostate Center Northwest, St. Antonius-Hospital, 33705 Gronau, Germany., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Krabbe LM; Department of Urology, University Hospital of Muenster, 48419 Muenster, Germany., Lau H; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.; Department of Pathology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA., Xing L; Department of Radiation Oncology, School of Medicine, Stanford University, Stanford, CA 94305, USA., Abbas M; Department of Pathology, University Hospital of Muenster, 48419 Muenster, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Oct 16; Vol. 15 (20). Date of Electronic Publication: 2023 Oct 16.
Autor:
Ho MD; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Black AJ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Zargar H; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Urology, Western Health, Melbourne, Australia., Fairey AS; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, United States.; University of Alberta, Edmonton, AB, Canada., Mertens LS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Dinney CP; Department of Urology, MD Anderson Cancer Center, Houston, TX, United States., Mir MC; Department of Urology, Fundacio Instituto Valenciano de Oncologia, Valencia, Spain., Krabbe LM; Department of Urology, University of Münster, Münster, Germany., Cookson MS; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, OK, United States., Jacobsen NE; University of Alberta, Edmonton, AB, Canada., Montgomery JS; Department of Urology, University of Michigan Health System, Ann Arbor, MI, United States., Yu EY; Department of Medicine, Division of Hematology/Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Center, Seattle, WA, United States., Xylinas E; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, United States., Kassouf W; Department of Surgery (Division of Urology), McGill University Health Centre, Montreal, QC, Canada., Dall'Era MA; Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, CA, United States., Vasdev N; Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, United Kingdom.; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom., Sridhar SS; Princess Margaret Cancer Centre, Toronto, ON, Canada., McGrath JS; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, United Kingdom., Aning J; Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, United Kingdom.; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, United Kingdom., Holzbeierlein JM; Department of Urology, University of Kansas Medical Center, Kansas City, KS, United States., Thorpe AC; Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, United Kingdom., Shariat SF; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, United States.; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria., Wright JL; Department of Urology, University of Washington, Seattle, WA, United States., Morgan TM; Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, CA, United States., Bivalacqua TJ; Department of Urology, University of Pennsylvania, Philadelphia, PA, United States., North S; Cross Cancer Institute, Edmonton, AB, Canada., Barocas DA; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, United States., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Grivas P; Department of Medicine, Division of Hematology/Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Center, Seattle, WA, United States., Stephenson AJ; Department of Urology, Rush University, Chicago, IL, United States., Shah JB; Department of Urology, Stanford University, Palo Alto, CA, United States., van Rhijn BW; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Daneshmand S; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, United States., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2023 Oct; Vol. 17 (10), pp. 301-309.
Autor:
Kirk PS; Department of Urology, University of Washington, Seattle, Washington., Lotan Y; Department of Urology, University of Texas Southwestern, Dallas, Texas., Zargar H; Department of Urology, Western Health, Melbourne, Australia., Fairey AS; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, California.; University of Alberta, Edmonton, Alberta, Canada., Dinney CP; Department of Urology, MD Anderson Cancer Center, Houston, Texas., Mir MC; Department of Urology, Fundacio Instituto Valenciano de Oncologia, Valencia, Spain., Krabbe LM; Department of Urology, University of Münster, Münster, Germany., Cookson MS; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma., Jacobson NE; University of Alberta, Edmonton, Alberta, Canada., Montgomery JS; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan., Vasdev N; Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, United Kingdom.; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom., Yu EY; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Fred Hutchinson Cancer Center, Seattle, Washington., Xylinas E; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, New York., Kassouf W; Division of Urology, Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada., Dall'Era MA; Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, California., Sridhar SS; Princess Margaret Hospital, Toronto, Ontario, Canada., McGrath JS; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, United Kingdom., Aning J; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom.; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, United Kingdom., Shariat SF; Department of Urology, University of Texas Southwestern, Dallas, Texas.; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, New York.; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria., Thorpe AC; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom., Morgan TM; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan., Holzbeierlein JM; Department of Urology, University of Kansas Medical Center, Kansas City, Kansas., Bivalacqua TJ; Department of Urology, University of Pennsylvania, Philadelphia, Pennsylvania., North S; Division of Urology, Cross Cancer Institute, Edmonton, Alberta, Canada., Barocas DA; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee., Grivas P; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Fred Hutchinson Cancer Center, Seattle, Washington., Garcia JA; Case Comprehensive Cancer Center, Cleveland, Ohio., Stephenson AJ; Department of Urology, Rush University, Chicago, Illinois., Shah JB; Department of Urology, Stanford University, Palo Alto, California., Daneshmand S; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, California., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany., Mertens L; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Black P; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Wright JL; Department of Urology, University of Washington, Seattle, Washington.; Fred Hutchinson Cancer Center, Seattle, Washington.
Publikováno v:
The Journal of urology [J Urol] 2023 May; Vol. 209 (5), pp. 882-889. Date of Electronic Publication: 2023 Feb 16.
Autor:
Wüstmann N; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Seitzer K; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Humberg V; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Vieler J; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Grundmann N; Institute for Bioinformatics, University Hospital Muenster, Muenster, Germany., Steinestel J; Department of Urology, University Hospital Augsburg, Augsburg, Germany., Tiedje D; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Duensing S; Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Heidelberg, Germany., Krabbe LM; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Bögemann M; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Schrader AJ; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany., Bernemann C; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany. christof.bernemann@ukmuenster.de., Schlack K; Department of Urology, University Hospital Muenster, Albert-Schweitzer Campus 1 A1, 48149, Muenster, Germany.
Publikováno v:
Biomarker research [Biomark Res] 2023 Apr 05; Vol. 11 (1), pp. 37. Date of Electronic Publication: 2023 Apr 05.
Autor:
Bernemann, C, Humberg, V, Steinestel, J, Schlack, K, Krabbe, LM, Bögemann, M, Schrader, AJ, Lennerz, J
Publikováno v:
66. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie; 20200312-20200313; Bochum; DOCV 3.4 /20200214/
Einleitung: Neue antihormonelle Therapeutika (ARTA) haben das Gesamtüberleben von Patienten mit metastasiertem kastrationsresistenten Prostatakarzinom (mCRPC) in den vergangenen Jahren deutlich verbessert. Dennoch kommt es auch hierunter zur Resiste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ece545f2c3fba926bd5338045bd238
Publikováno v:
66. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie; 20200312-20200313; Bochum; DOCV 2.6 /20200214/
Einleitung: Die Liquid Biopsy, d.h. die Blutentnahme mit dem Ziel, Aussagen über die Krebserkrankung eines Patienten zu treffen, hat in den letzten Jahren große Fortschritte erzielt. So ist das EpCAM-basierte Cellsearch®-System als Detektionssyste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3e28de7de3b9706dbe16ce3b4df255